financetom
Business
financetom
/
Business
/
Terex Insider Sold Shares Worth $756,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Terex Insider Sold Shares Worth $756,000, According to a Recent SEC Filing
May 28, 2024 11:58 AM

02:37 PM EDT, 05/28/2024 (MT Newswires) -- Scott Posner, Senior Vice President, General Counsel, Secretary, on May 24, 2024, sold 12,500 shares in Terex ( TEX ) for $756,000. Following the Form 4 filing with the SEC, Posner has control over a total of 58,224 shares of the company, with 58,224 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/97216/000009721624000109/xslF345X03/wk-form4_1716921065.xml

Price: 60.00, Change: -0.98, Percent Change: -1.60

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Ascentage Pharma Says China Regulator Approves Treatment for Chronic Lymphocytic Leukemia
Ascentage Pharma Says China Regulator Approves Treatment for Chronic Lymphocytic Leukemia
Jul 10, 2025
09:52 AM EDT, 07/10/2025 (MT Newswires) -- Ascentage Pharma ( AAPG ) said Thursday that lisaftoclax has been approved by China's National Medical Products Administration for the treatment of adult patients with chronic lymphocytic leukemia/small lymphocytic lymphoma who have previously received at least one systemic therapy, including Bruton's tyrosine kinase inhibitors. Lisaftoclax is the first Bcl-2 inhibitor to receive conditional...
Factbox-Trump's tariffs: What's in effect and what could be in store?
Factbox-Trump's tariffs: What's in effect and what could be in store?
Jul 10, 2025
WASHINGTON (Reuters) -U.S. President Donald Trump has launched a global trade war with an array of tariffs that target individual products and countries.  Trump has set a baseline tariff of 10% on all imports to the United States, as well as additional duties on certain products or countries.  Here is a list of targeted tariffs he has implemented or threatened...
Intuitive Surgical Says Vessel Sealer Electrosurgical Instrument Gets FDA Approval
Intuitive Surgical Says Vessel Sealer Electrosurgical Instrument Gets FDA Approval
Jul 10, 2025
09:53 AM EDT, 07/10/2025 (MT Newswires) -- Intuitive Surgical ( ISRG ) said Thursday the US Food and Drug Administration approved its Vessel Sealer Curved, an electrosurgical instrument that is designed to seal, cut, grasp, and dissect tissue, for use with the company's da Vinci systems. The company said this is its first advanced energy instrument to obtain FDA clearance...
Copyright 2023-2026 - www.financetom.com All Rights Reserved